Compugen (CGEN) Cash from Operations (2009 - 2010)
Compugen's (CGEN) quarterly Cash from Operations came in at 831000.0 in Q4 2010, up 60.05% year-on-year from 519218.98 in Q4 2009, and down 99.76% quarter-over-quarter from 416000.0 in Q3 2010.
Compugen (CGEN) Cash from Operations (2009 - 2010) Analysis & Trends
Compugen has disclosed Cash from Operations across 2 years of filings, most recently posting 831000.0 for Q4 2010.
- Cash from Operations for Q4 2010 came in at 831000.0, up 60.05% year-over-year; the trailing twelve-month figure through Dec 2010 was 4280000.0 (changed N/A YoY), and the FY2025 annual result was 31634000.0, down 36.23% from the prior year.
- Cash from Operations came in at 831000.0 for Q4 2010 at Compugen, down from 416000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 416000.0 in Q3 2010 to a low of 2080000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -831,000.00 |
| Dec 31, 2010 | -831,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Sep 30, 2010 | -416,000.00 |
| Dec 31, 2009 | -2.08 Mn |
| Dec 31, 2009 | -2.08 Mn |
| Sep 30, 2009 | -953,000.00 |
| Sep 30, 2009 | -953,000.00 |